Showing results (1711-1720 of 1,802) with videos related to

Sort By:
Pageof 181
Cancer Research|June 5, 2001
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesisK Moriya, K Nakagawa, T Santa, et al.
Bioorganic & Medicinal Chemistry|January 30, 1999
Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activityM Koizumi, R Koga, H Hotoda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1997
[Epstein-Barr virus-infected T-cell malignancy in an adult patient with Behçet's disease-like symptoms]M Ueda, Y Kobayashi, K Yoshimori, et al.
Journal of Inherited Metabolic Disease|April 5, 2001
Genetic analysis of phytosterolaemiaM Togo, T Toda, L A Nguyen, et al.
The Journal of Hospital Infection|June 10, 2023
Whole-genome sequencing analysis of molecular epidemiology and silent transmissions causing meticillin-resistant Staphylococcus aureus bloodstream infections in a university hospitalT Sato, T Yamaguchi, K Aoki, et al.
Journal of Viral Hepatitis|March 16, 2013
An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis CH Takahashi, T Mizuta, S Oeda, et al.
Bone Marrow Transplantation|November 10, 2009
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantationS Kimura, K Oshima, S Okuda, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 10, 2000
Clinical evaluation of the Gyro Pump C1E3 as a cardiopulmonary bypass pumpY Orime, M Shiono, S Yagi, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Cell Death and Differentiation|May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJ Kuroda, S Kimura, A Strasser, et al.
Pageof 181